Deferred Income Tax Liabilities, Net of ORAMED PHARMACEUTICALS INC. for 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
ORAMED PHARMACEUTICALS INC. quarterly Deferred Income Tax Liabilities, Net in USD history and change rate for 30 Sep 2025.
  • ORAMED PHARMACEUTICALS INC. Deferred Income Tax Liabilities, Net for the quarter ending 30 Sep 2025 was $7,921,000.
Source SEC data
View on sec.gov
Deferred Income Tax Liabilities, Net, Quarterly (USD)

ORAMED PHARMACEUTICALS INC. Quarterly Deferred Income Tax Liabilities, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,921,000 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.